Health
Despite Drug Industry Claims, Higher List Prices Do Mean Higher Out-of-Pocket Costs for Many Patients – Gizmodo Australia
New research suggests that as the list price of brand name drugs rise, so do out-of-pocket medical costs for these drugs — at least for some patients. This is counter…
New research suggests that as the list price of brand name drugs rise, so do out-of-pocket medical costs for these drugs at least for some patients. This is counter to a common industry claim that patients arent affected by list price increases. The study found a link between list prices rising and out-of-pocket increases among people with private insurance plans that mandated deductibles and coinsurance. These patients also didnt seem to benefit from rebates passed down by drug makers to insurance…
-
Business22 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News22 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business18 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News21 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses